Bruce Woolcock

Centre for Lymphoid Cancer BC Cancer Agency

Claim

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 55 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

时间

引用量

主题

期刊级别

合作者

合作机构

TRAF3 Loss-of-Function Reveals the Non-Canonical NF-Κb Pathway As a Therapeutic Target in Diffuse Large B-Cell Lymphoma

Michael Y. Li,Lauren C. Chong,Gerben Duns,Andrew Lytle,Bruce Woolcock,Aixiang Jiang,Adele Telenius,Susana Ben-Neriah, Waqas Nawaz,Graham W. Slack,Ingrid Elisia,Elena Vigano,Tomohiro Aoki,Shannon Healy,Gerald Krystal,Leandro Venturutti,David W. Scott,Christian Steidl

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA（2024）

Cited0Views0WOSBibtex

Multiomic Profiling Reveals Pleiotropic Effects of Somatic IRF4-C99R Mutations in Primary Mediastinal Large B-Cell Lymphomas

Shinya Rai,Gerben Duns,Fabian Frontzek,Jasper Wong,Yifan Yin,Shannon Healy,Michael Yu Li, Makoto Kishida,Elena Viganò,Manabu Fujisawa,Bruce Woolcock,Adele Telenius,Barbara Meissner,Merrill Boyle,Hisae Nakamura, Luke O'Brien,Andrew Lytle,Pedro Farinha,Graham W. Slack,Laura K. Hilton,Ryan Morin,Leandro Venturutti,Tomohiro Aoki,Kerry J. Savage,David W. Scott,Christian Steidl

Bloodno. Supplement 1 (2024): 2966-2966

Cited0Views0Bibtex

Supplementary Table S4-5 from Molecular and Genetic Characterization of MHC Deficiency Identifies EZH2 As Therapeutic Target for Enhancing Immune Recognition

Daisuke Ennishi, Katsuyoshi Takata,Wendy Béguelin,Gerben Duns,Anja Mottok,Pedro Farinha,Ali Bashashati,Saeed Saberi,Merrill Boyle,Barbara Meissner,Susana Ben-Neriah,Bruce W. Woolcock,Adèle Telenius,Daniel Lai,Matt Teater,Robert Kridel,Kerry J. Savage,Laurie H. Sehn,Ryan D. Morin,Marco A. Marra,Sohrab P. Shah,Joseph M. Connors,Randy D. Gascoyne,David W. Scott,Ari M. Melnick,Christian Steidl

openalex（2023）

Cited0Views0Bibtex

Supplementary Table S6-7 from Molecular and Genetic Characterization of MHC Deficiency Identifies EZH2 As Therapeutic Target for Enhancing Immune Recognition

Daisuke Ennishi,Katsuyoshi Takata,Wendy Béguelin,Gerben Duns,Anja Mottok,Pedro Farinha,Ali Bashashati,Saeed Saberi,Merrill Boyle,Barbara Meissner,Susana Ben-Neriah,Bruce W. Woolcock,Adèle Telenius,Daniel Lai,Matt Teater,Robert Kridel,Kerry J. Savage,Laurie H. Sehn,Ryan D. Morin,Marco A. Marra,Sohrab P. Shah,Joseph M. Connors,Randy D. Gascoyne,David W. Scott,Ari M. Melnick,Christian Steidl

openalex（2023）

Cited0Views0Bibtex

Supplementary Table S11 and 15 from Molecular and Genetic Characterization of MHC Deficiency Identifies EZH2 As Therapeutic Target for Enhancing Immune Recognition

openalex（2023）

Cited0Views0Bibtex

Supplementary Table S8-9 from Molecular and Genetic Characterization of MHC Deficiency Identifies EZH2 As Therapeutic Target for Enhancing Immune Recognition

openalex（2023）

Cited0Views0Bibtex

Supplementary Table S12-14 from Molecular and Genetic Characterization of MHC Deficiency Identifies EZH2 As Therapeutic Target for Enhancing Immune Recognition

openalex（2023）

Cited0Views0Bibtex

Supplementary Table S1-3 from Molecular and Genetic Characterization of MHC Deficiency Identifies EZH2 As Therapeutic Target for Enhancing Immune Recognition

openalex（2023）

Cited0Views0Bibtex

Supplementary Methods and Figures from Molecular and Genetic Characterization of MHC Deficiency Identifies EZH2 As Therapeutic Target for Enhancing Immune Recognition

openalex（2023）

Cited0Views0Bibtex

Supplementary Table S10 from Molecular and Genetic Characterization of MHC Deficiency Identifies EZH2 As Therapeutic Target for Enhancing Immune Recognition

openalex（2023）

Cited0Views0Bibtex

Author Statistics

#Papers: 55

#Citation: 7279

H-Index: 23

G-Index: 37

Sociability: 6

Diversity: 2

Activity: 2

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn